Navigation Links
Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
Date:11/19/2007

Highly-Regarded Research Flow Cytometry Portfolio Targeted at Fast Growing

Market Segment

FULLERTON, Calif., and GLOSTRUP, Denmark, Nov. 19 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer of products that simplify and automate complex biomedical testing, and Dako Denmark A/S, a world leader in cancer diagnostics, announced today that Beckman Coulter will acquire Dako's research flow cytometry instrumentation business, which is based in Fort Collins, Colorado. Financial terms were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Scott Garrett, Beckman Coulter's president and chief executive officer, said, "We are enthusiastic about the opportunity to add Dako's MoFlo XDP high-performance sorter, the gold standard for cell sorting, and the highly capable nine-color CyAn research flow cytometer to our existing portfolio of cytometry instruments. This transaction allows us to offer a more comprehensive range of research solutions to our customers."

Dako's president and CEO, Patrik Dahlen, said, "This action reinforces our strategic intent to create a more focused business in anatomic pathology and tissue-based cancer diagnostics. We believe our flow cytometry instrumentation products are an excellent match for Beckman Coulter and will achieve even greater success when combined with the company's existing flow cytometry infrastructure and reputation for quality, service and support."

Dako's flow cytometry instrument business workforce of almost 200 people includes sales, marketing, research, manufacturing and administrative personnel. Flow cytometry is used to analyze cells in blood and other fluids for both research applications and diagnosis of diseases such as leukemia, lymphoma and HIV.

Garrett added, "I want to welcome the talented people transferring to us from Dako. We see significant opportunities for Beckman Coulter in flow cytometry and continue to expand our investment in this fast-growing market segment."

The transaction is expected to close by the end of the year. More information about the transaction will be available during Beckman Coulter's 2007 Annual Business Review meeting on December 11. Contact Investor Relations for details.

About Dako

Dako, which is headquartered in Denmark, strives to improve tissue-based cancer diagnostics focusing on the workflow in the pathology laboratory. The company develops and markets instruments, reagents and software that will reduce time from biopsy to diagnosis, improve the quality and reliability of diagnosis, and increase efficiency in the lab. For information, visit http://www.dako.com.

About Beckman Coulter, Inc.

Based in Fullerton, California, Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue consisting of supplies, test kits, service and operating-type lease payments represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.

Forward Looking Statements

This press release contains forward-looking statements, including statements regarding the contribution of the acquisition to Beckman Coulter's R&D and product development capability. These statements are based on current expectations and assumptions. Actual results could differ materially from those anticipated by these forward-looking statements as a result of a number of factors, some of which may be beyond Beckman Coulter's control. Beckman Coulter disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contacts: Mary Luthy, Beckman Coulter Robert Raynor, Beckman Coulter

Corporate Communications Investor Relations

(714) 773-7964 (714) 773-7620

Leif Norgaard, Dako Group

Chief Financial Officer

+45 2088 7280


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
5. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
6. Food Bank For New York City Acquires FoodChange
7. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
8. AMERIGROUP to Acquire Memphis Health Plan
9. Concentra Acquires Assets of Renew Health & Wellness
10. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
11. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of McKinney ... Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. ... to Highway 121. , As the practice has grown, the need for more space ...
(Date:2/24/2017)... Diego, CA (PRWEB) , ... February 24, 2017 , ... ... its 2017 national conference convening academic faculty engaged in or interested in palliative care ... and Research,” will be held in North County San Diego on Sept. 28 ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that ... Chairman of the Management Committee when IFN was originally formed in 2002 where he ... and development of the business plan. He became the first paid employee of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... 2017 , ... On February 22, 2017 the U.S. Department ... withdraw previous guidance issued by the Obama Administration requiring schools to treat transgender ... by the Obama Administration came in response to a growing number of states ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... CHEYENNE, Wyoming , Feb. 24, 2017  Xynomic ... company, today announced that it has acquired exclusive ... a potentially best-in-class innovative HDAC inhibitor targeting hematological ... total of 14 Phase 1 and 2 clinical ... Asia have already been completed, ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... 2016" report to their offering. ... The latest research Autism Spectrum Disorder Drugs ... benchmarks in the global Autism Spectrum Disorder market. The research ... the key drugs marketed for Autism Spectrum Disorder and their clinical ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
Breaking Medicine Technology: